Collaboration between the
public academy and pharmaceuticals

Supported by the Innovative Medicines Initiative (IMI)

Research for the development of
precision medicine strategies

Investigating systemic
autoimmune diseases…

Systemic lupus erythematosus, systemic sclerosis, Sjögren’s syndrome,
rheumatoid arthritis, primary antiphospholipid syndrome , mixed connective tissue disease

  • Welcome to PRECISESADS

    PRECISESADS is an EU project formed by 21 academic, 2 SMEs and 5 industrial partners from 12 countries spread right across Europe, planned for 5 years with a budg...
    Read more
  • UPDATE! News & Events

    PRECISESADS General Assembly & SC meeting

    Paris, Grance, March 9-10, 2017

    Read more
  • PRECISESADS Partner profile

    KU Leuven is an autonomous university working together actively with its research partners at home and abroad
    Read more


Inflammatory autoimmune diseases such as rheumatoid arthritis and lupus affect 1-3% of the population, and while treatments exist, these are costly and have a number of serious side effects. There is growing evidence that many of these conditions may be incorrectly classified. The PRECISESADS project will study 2 500 people with various autoimmune diseases, gathering data on the molecular causes of their disease as well as their clinical symptoms. Using this information, they will pave the way for a new classification of these diseases, something that will allow doctors to offer patients more personalised treatments at an earlier stage of their disease.


Latest Project News

    • 22 SEP 16
    • 0
    PRECISESADS hits 2 000 mark on patient recruitment

    PRECISESADS hits 2 000 mark on patient recruitment

    PRECISESADS, an IMI funded project, has now recruited over 2 000 people into its pan-European clinical study on systemic autoimmune diseases such as rheumatoid arthritis and lupus. This milestone means that the project is well on track towards its final goal of recruiting a total of 2 500 people from across 9 different countries.

    • 01 APR 16
    • 0
    PRECISESADS General Assembly in Granada, 9th of March 2016

    PRECISESADS General Assembly in Granada, 9th of March 2016

    The annual general assembly of the PRECISESADS project took place in Granada on March 2016. More than 70 participants representing the 28 members of the consortium and advisory board have discussed the latest project updates and future steps, including the preparation of the IMI review meeting in Brussels.


  • Information for Patients & Patients Associations

    General information, list of patients associations, …

Project partners